Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Money, coercion, and undue inducement: attitudes about payments to research participants.

Literature DB >> 22338401

Money, coercion, and undue inducement: attitudes about payments to research participants.

Emily A Largent¹, Christine Grady, Franklin G Miller, Alan Wertheimer.

Abstract

Entities: Disease Species

Mesh：

Year: 2012 PMID： 22338401 PMCID： PMC4214066

Source DB: PubMed Journal: IRB ISSN： 0193-7758

× No keyword cloud information.

10 in total

1. Paying research subjects: an analysis of current policies.

Authors: Neal Dickert; Ezekiel Emanuel; Christine Grady
Journal: Ann Intern Med Date: 2002-03-05 Impact factor: 25.391

2. The influence of risk and monetary payment on the research participation decision making process.

Authors: J P Bentley; P G Thacker
Journal: J Med Ethics Date: 2004-06 Impact factor: 2.903

3. Undue inducement: nonsense on stilts?

Authors: Ezekiel J Emanuel
Journal: Am J Bioeth Date: 2005 Sep-Oct Impact factor: 11.229

4. Payment for research participation: a coercive offer?

Authors: A Wertheimer; F G Miller
Journal: J Med Ethics Date: 2008-05 Impact factor: 2.903

5. Payment of clinical research subjects.

Authors: Christine Grady
Journal: J Clin Invest Date: 2005-07 Impact factor: 14.808

6. Why do we pay? A national survey of investigators and IRB chairpersons.

Authors: Elizabeth Ripley; Francis Macrina; Monika Markowitz; Chris Gennings
Journal: J Empir Res Hum Res Ethics Date: 2010-09 Impact factor: 1.742

7. An analysis of U.S. practices of paying research participants.

Authors: Christine Grady; Neal Dickert; Tom Jawetz; Gary Gensler; Ezekiel Emanuel
Journal: Contemp Clin Trials Date: 2005-03-28 Impact factor: 2.226

8. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials.

Authors: Scott D Halpern; Jason H T Karlawish; David Casarett; Jesse A Berlin; David A Asch
Journal: Arch Intern Med Date: 2004-04-12

9. Paying Clinical Research Participants: One Institution's Research Ethics Committees' Perspective.

Authors: Elizabeth B D Ripley; Frank L Macrina; Monika Markowitz
Journal: J Empir Res Hum Res Ethics Date: 2006-12 Impact factor: 1.742

10. The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research.

Authors:
Journal: J Am Coll Dent Date: 2014

10 in total

36 in total

9. Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials.

Authors: Jill A Fisher
Journal: Sci Technol Human Values Date: 2015-03-01

10. How IRBs view and make decisions about coercion and undue influence.

Authors: Robert Klitzman
Journal: J Med Ethics Date: 2012-09-14 Impact factor: 2.903

Money, coercion, and undue inducement: attitudes about payments to research participants.

1. Paying research subjects: an analysis of current policies.

2. The influence of risk and monetary payment on the research participation decision making process.

3. Undue inducement: nonsense on stilts?

4. Payment for research participation: a coercive offer?

5. Payment of clinical research subjects.

6. Why do we pay? A national survey of investigators and IRB chairpersons.

7. An analysis of U.S. practices of paying research participants.

8. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials.

9. Paying Clinical Research Participants: One Institution's Research Ethics Committees' Perspective.

10. The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research.

1. Nudges and coercion: conceptual, empirical, and normative considerations.

2. Research participation by low-income and racial/ethnic minority groups: how payment may change the balance.

3. Avoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation.

4. Return of Genetic Research Results to Participants and Families: IRB Perspectives and Roles.

5. The Role of Inclusion Benefits in Ethics Committee Assessment of Research Studies.

6. Paying Research Participants: The Outsized Influence of "Undue Influence".

7. Coercion as Subjection and the Institutional Review Board.

8. Compensation for egg donation: a zero-sum game.

9. Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials.

10. How IRBs view and make decisions about coercion and undue influence.